The nurse is caring for a 27-year-old African American woman who was just prescribed an ACE inhibitor for the management of her hypertension.
What should be advised related to contraception?
No special precautions need to be taken.
The use of spermicidal jellies is recommended.
The minipill is the contraceptive of choice.
Use barrier contraception to prevent pregnancy while taking these drugs.
The Correct Answer is D
Choice A rationale
ACE inhibitors can cause teratogenic effects, meaning they can harm a developing fetus. Therefore, precautions should be taken to avoid pregnancy while taking these drugs.
Choice B rationale
Spermicidal jellies alone are not a highly reliable form of contraception. For women taking ACE inhibitors, a more reliable method of contraception is recommended to prevent pregnancy.
Choice C rationale
The minipill, a progestin-only contraceptive, is not the contraceptive of choice when the risk of teratogenic effects from ACE inhibitors is considered. Barrier methods are preferred to avoid potential drug interactions.
Choice D rationale
Barrier contraception, such as condoms or diaphragms, is recommended for women taking ACE inhibitors to prevent pregnancy due to the teratogenic risk associated with these drugs.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is A
Explanation
Step 1 is (120 mL ÷ 60 min) × 15 gtt/mL.
Step 2 is (2 mL/min) × 15 gtt/mL.
Step 3 is 30 gtt/min.
Final calculated answer is 30 gtt/min.
Correct Answer is C
Explanation
Choice A rationale
Working with animals is typically done in preclinical trials before phase I studies in humans and is not part of phase III drug evaluation studies.
Choice B rationale
Conducting research to determine the effectiveness of the drug is part of phase II studies. Phase III studies focus more on confirming effectiveness, monitoring side effects, and comparing it to commonly used treatments.
Choice C rationale
Monitoring and observing patients closely for adverse effects is a key responsibility in phase III drug evaluation studies. These studies involve a larger patient population to gather comprehensive safety and efficacy data.
Choice D rationale
Choosing appropriate patients to be involved in the study is primarily the responsibility of researchers and clinicians during the earlier phases of drug development, such as phase I and phase II studies.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.